Literature DB >> 9447595

Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries.

S P Ho1, Y Bao, T Lesher, R Malhotra, L Y Ma, S J Fluharty, R R Sakai.   

Abstract

Antisense experiments are often complicated by the lack of reliable methods for selecting effective antisense sequences. Chimeric oligodeoxynucleotide (ODN) libraries and ribonuclease H (RNase H) were used to identify regions on the 1253 nucleotide angiotensin type-1 receptor (AT1) mRNA that are accessible to hybridization with antisense ODNs. Phosphorothioate antisense ODNs targeted against accessible sites reduced AT1 receptor levels by at least 50% in cell culture. ODNs to 4 sites produced a 70% to 80% reduction. In contrast, most sequences targeted between accessible sites were ineffective. When injected into the brains of rats, ODNs targeted to accessible sites reduced AT1 (by 65%) but not AT2 receptor levels. Additionally, AT1 receptor function as measured by agonist-induced water intake, was significantly attenuated in these rats. ODNs directed between accessible sites were ineffective at suppressing water intake. RNA mapping can be applied to any RNA target to facilitate selection of multiple, active antisense sequences for cell culture and in vivo experiments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9447595     DOI: 10.1038/nbt0198-59

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  42 in total

1.  Predicting oligonucleotide affinity to nucleic acid targets.

Authors:  D H Mathews; M E Burkard; S M Freier; J R Wyatt; D H Turner
Journal:  RNA       Date:  1999-11       Impact factor: 4.942

2.  Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers.

Authors:  A A Mir; T J Lockett; P Hendry
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 3.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

4.  Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.

Authors:  M Amarzguioui; G Brede; E Babaie; M Grotli; B Sproat; H Prydz
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

5.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

6.  5'-bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure.

Authors:  E Kostenko; M Dobrikov; D Pyshnyi; V Petyuk; N Komarova; V Vlassov; M Zenkova
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

7.  The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides.

Authors:  M Sohail; S Akhtar; E M Southern
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

8.  Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.

Authors:  M Sohail; H Hochegger; A Klotzbücher; R L Guellec; T Hunt; E M Southern
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

9.  Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.

Authors:  Peter A C 't Hoen; Ruud Out; Jan N M Commandeur; Nico P E Vermeulen; F H D van Batenburg; Muthiah Manoharan; Theo J C van Berkel; Erik A L Biessen; Martin K Bijsterbosch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

10.  Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.

Authors:  Angelika Gabler; Stefan Krebs; Doris Seichter; Martin Förster
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.